ASENSUS SURGICAL, INC. (TRXC) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues:
Asia	0.9	2.1
Non-US	6.3	1.1	2.3	8.0	20.3
UNITED STATES	0.3	1.0	0.8	0.5	3.8
Other		4.0
Total revenues	7.1	8.2	3.2	8.5	24.1	7.1	1.5	46.8
Revenue growth [+]	-13.9%	159.3%	-62.8%	-64.6%	238.9%	368.1%	-96.8%	11563.6%
Asia	-58.7%
Non-US	455.8%	-51.1%	-70.9%	-60.7%
UNITED STATES	-71.0%	21.7%	58.4%	-85.8%
Cost of goods sold	10.9	11.1	5.2	20.7	16.2	6.7	1.1	46.4
Gross profit	-3.8	-2.9	-2.0	-12.2	7.9	0.4	0.5	0.4
Gross margin	-53.4%	-34.8%	-62.7%	-143.0%	32.9%	5.4%	29.6%	0.9%
Selling, general and administrative [+]	34.9	32.7	27.2	46.8	39.6	29.8	20.0	10.7
Sales and marketing	14.8	13.4	13.1	28.0	25.7	17.5	9.2	2.9
General and administrative	20.2	19.3	14.1	18.8	13.9	12.3	10.8	7.8
Research and development	28.9	19.3	16.6	22.5	21.8	22.0	29.3	29.7
Other operating expenses				-15.9	-14.8	8.5	9.5	2.6
EBITDA [+]	-64.3	-52.1	-42.9	-63.4	-36.2	-49.6	-49.4	-39.1
EBITDA growth	23.5%	21.3%	-32.3%	75.0%	-26.9%	0.3%	26.3%	10.8%
EBITDA margin	-907.1%	-632.6%	-1351.7%	-743.2%	-150.3%	-696.9%	-3252.8%	-83.6%
Depreciation	3.4	2.9	2.9	2.2	2.4	2.5	1.9	1.2
EBITA	-67.7	-54.9	-45.8	-65.6	-38.6	-52.0	-51.4	-40.4
EBITA margin	-954.6%	-667.3%	-1442.9%	-768.6%	-160.4%	-731.9%	-3380.6%	-86.3%
Amortization of intangibles	7.7	11.3	10.8	10.3	10.9	7.9	7.0	2.2
EBIT [+]	-75.4	-66.2	-56.6	-75.9	-49.5	-59.9	-58.3	-42.5
EBIT growth	13.9%	16.9%	-25.4%	53.2%	-17.3%	2.7%	37.1%	16.2%
EBIT margin	-1063.4%	-804.0%	-1783.1%	-889.4%	-205.4%	-842.4%	-3839.3%	-91.0%
Non-recurring items [+]	0.3	-1.6	3.8	78.7	-0.4	2.0	65.3	3.8
Asset impairment	1.4			86.9			61.8
Unusual expense					-1.0	2.0	0.5	-0.4
Loss on contingent liability	-1.1	-1.6	2.9	-9.6
Interest expense, net [+]	-0.7	-0.2	0.0	3.0	2.8	2.1	1.9	1.6
Interest expense	0.4	0.4	0.0	3.6	4.2	2.4	2.0	1.6
Interest income	1.1	0.6	0.0	0.6	1.4	0.3	0.1
Other income (expense), net [+]	-0.3	2.2	-0.5	0.3	-13.2	-84.0	0.0
Gain (loss) on debt retirement		2.8		-1.0
Change in fair value of warrants		-2.0	-0.3	2.2	-14.3	-83.7
Write-off of deferred debt issuance costs		2.8		-1.0
Other	-0.3	0.0	-0.1	-1.0	1.1	-0.3	0.0
Pre-tax income	-75.2	-62.2	-60.8	-157.3	-65.2	-148.1	-125.5	-48.0
Income taxes	0.3	0.2	-1.5	-3.1	-3.4	-3.3	-5.5	-1.0
Tax rate			2.5%	2.0%	5.2%	2.2%	4.4%	2.1%
Net income	-75.6	-62.5	-60.0	-154.2	-61.8	-144.8	-120.0	-46.9
Net margin	-1066.2%	-758.8%	-1890.5%	-1807.5%	-256.3%	-2036.2%	-7898.6%	-100.4%

Basic EPS [+]	($0.32)	($0.28)	($0.85)	($8.69)	($3.88)	($0.97)	($1.07)	($0.59)
Growth	16.1%	-67.5%	-90.2%	124.3%	298.2%	-9.0%	81.4%	-8.1%
Diluted EPS [+]	($0.32)	($0.28)	($0.85)	($8.69)	($3.88)	($0.97)	($1.07)	($0.59)
Growth	16.1%	-67.5%	-90.2%	124.3%	298.2%	-9.0%	81.4%	-8.1%

Shares outstanding (basic) [+]	236.5	227.0	70.8	17.7	15.9	148.7	112.2	79.6
Growth	4.2%	220.5%	299.2%	11.3%	-89.3%	32.6%	40.9%	35.6%
Shares outstanding (diluted) [+]	236.5	227.0	70.8	17.7	15.9	148.7	112.2	79.6
Growth	4.2%	220.5%	299.2%	11.3%	-89.3%	32.6%	40.9%	35.6%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.